NCT00433576View on ClinicalTrials.gov

Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

November 30, 2008

Study Completion Date

March 31, 2009

Conditions
Adenocarcinoma of the ColonAdenocarcinoma of the RectumStage I Colon CancerStage I Rectal CancerStage II Colon CancerStage II Rectal CancerStage III Colon CancerStage III Rectal Cancer
Interventions
DRUG

resveratrol

Given orally

OTHER

pharmacological study

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00433576 - Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery | Biotech Hunter | Biotech Hunter